Multiple risk factors were associated with denials and longer wait times for biologic treatment in moderate to severe asthma, ...

AstraZeneca is hopping on the pickleball craze for the latest iteration of its Stepping Back Out campaign for asthma ...

A 12-month interim analysis of the AGILE Phase III extension study confirms the long-term safety and efficacy of twice-yearly ...

Discover a study that compared the effectiveness of P043 versus omalizumab in managing uncontrolled allergic asthma.

The "Inhalable Biologics Market Size, Share & Trends Analysis Report by Biologics (Peptides & Proteins, Monoclonal Antibodies, RNAi-Based Therapeutics), Application (Diabetes, Cancer), Dosage Form, ...

Learn the vital steps to take when someone experiences a severe asthma attack, from recognizing danger signs to administering ...

Leukotriene Modifiers: These are oral medications that help control inflammation in the airways, and they are often used as add-on therapies, particularly for asthma. Biologics: This category includes ...

Asthma inhalers are one type of allergic asthma medication that can help when symptoms begin. Find out which other types of ...

Incyte's revenues continues to grow, with full-year 2024 revenues reaching $4.2 billion, driven by JAKAFI and OPZELURA. Click ...

The Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for depemokimab for asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps ...

Asthma treatment has evolved significantly with the introduction of biologic therapies that target specific immune cells and cytokines. However, their efficacy remains a topic of debate.